KIRKSTALL
Desconocido
CyGenTiG: Cypergenetic Tissue Engineering
KIRKSTALL LIMITED
participó en un
H2020:
H2020-FETOPEN-2016-2017
This project addresses a serious bottleneck to the widespread availability of engineered tissues for clinical use: Currently, building of ne...
2018-05-03 - 2024-03-31 | Financiado
2018-05-03 - 2024-03-31 | Financiado
INLIVETOX: Intestinal Liver and Endothelial Nanoparticle Toxicity Development and evaluation of a novel tool...
KIRKSTALL LIMITED
participó en un
FP7:
The InLiveTox project will form an interdisciplinary consortium at the European level, together with a key American research group to develo...
Financiado
Financiado
* No se disponen de datos de la empresa actual.